Nektar TherapeuticsNKTR stock score: 27/100

$32.54 · -5.46% · Scored Nov 19, 2026

Technical
25
Fundamental
28
News
41

The reading

Nektar Therapeutics (NKTR) scores 27 out of 100, which reads bearish, higher than 2% of Healthcare stocks and 2% of the 4,118 US stocks we score.

The composite weights fundamentals 80% and technicals 20%: fundamentals read 28, technicals 25.

Among the fundamentals, Quick Ratio at 100 and Price Target at 100 score highest, while Earnings Profitability (Quarterly) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 14 and contrarian oscillators 69 — a split worth reading before trusting the technical total.

News sentiment is neutral at 41; it is shown, not counted in the composite.

Since Aug 22, 2026 the composite has ranged from 25 to 50, and it is down 14 points over the period.

About Nektar Therapeutics

Nektar Therapeutics (NKTR) is a clinical-stage biotechnology company focused on treatments that work by modulating the immune system. Its lead product candidate is rezpegaldesleukin, often called rezpeg, a drug designed to stimulate regulatory T cells, which help calm overactive immune responses. Rezpeg is in late-stage development for moderate-to-severe atopic dermatitis, and the company plans a late-stage study in severe alopecia areata after mid-stage trials in both conditions. The U.S. Food and Drug Administration has granted Fast Track designation for rezpeg in both indications. Nektar also has earlier-stage immunology programs drawn from its research platform. The company built much of its history on polymer chemistry technology used in medicines sold by larger drugmakers, but it has since narrowed its focus to its own immunology pipeline. Nektar has little product revenue and funds its research mainly with its cash reserves and sales of stock.

Nektar competes with makers of approved and developing treatments for atopic dermatitis and alopecia areata, including Sanofi and Regeneron, Eli Lilly, AbbVie and Pfizer. Its edge rests on rezpeg’s different mechanism, which aims to restore immune balance rather than block a single inflammatory signal, and the potential for less frequent dosing. Investors who follow NKTR stock tend to watch enrollment and results from the late-stage atopic dermatitis program. Durability data and plans for alopecia areata are closely followed. Cash runway, potential partnerships and share dilution are other factors.

What’s driving the score

The strongest and weakest of the scorers that count toward NKTR’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

28

Pulling it up

  • Quick ratio measures a company's ability to meet short-term obligations with liquid assets.

  • Price target score compares the current stock price to analyst consensus targets.

  • Current assets divided by current liabilities: the ability to pay short-term bills.

Holding it back

  • Earnings Profitability (Quarterly) measures recent profitability using trailing 12-month quarterly data.

  • Absolute profitability: whether the company is profitable, its net margin against the sector range, and how consistently it has been profitable over three years.

  • 5-year earnings growth evaluates long-term profit trajectory and consistency.

37 weighted scorers; 2 had no data today and are left out rather than counted as zero.

Technical · daily

20

Pulling it up

  • Bollinger Bands (20-period) plot standard deviations above and below a moving average.

  • Relative Strength Index (14-period) measures momentum by comparing recent gains to losses.

  • Williams %R (28-period) places the close within the last 28 periods' high-low range.

Holding it back

  • Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.

  • Where the price sits between its 52-week low and high.

  • Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
41

Technical score by timeframe

ChartScoreWeight
Hourly281
Daily203
Weekly242
Monthly302
Quarterly272

Composite score, last 90 days

05010027Aug 22, 2026Nov 19, 2026Aug 22, 2026: 41Aug 23, 2026: 41Aug 24, 2026: 39Aug 25, 2026: 41Aug 26, 2026: 41Aug 27, 2026: 41Aug 28, 2026: 39Aug 29, 2026: 39Aug 30, 2026: 39Aug 31, 2026: 37Sep 1, 2026: 39Sep 2, 2026: 40Sep 3, 2026: 50Sep 4, 2026: 40Sep 5, 2026: 41Sep 6, 2026: 41Sep 7, 2026: 41Sep 8, 2026: 42Sep 9, 2026: 38Sep 10, 2026: 36Sep 11, 2026: 36Sep 12, 2026: 36Sep 13, 2026: 36Sep 14, 2026: 35Sep 15, 2026: 34Sep 16, 2026: 34Sep 17, 2026: 35Sep 18, 2026: 35Sep 19, 2026: 36Sep 20, 2026: 36Sep 21, 2026: 34Sep 22, 2026: 31Sep 23, 2026: 31Sep 24, 2026: 31Sep 25, 2026: 30Sep 26, 2026: 29Sep 27, 2026: 29Sep 28, 2026: 31Sep 29, 2026: 31Sep 30, 2026: 32Oct 1, 2026: 28Oct 2, 2026: 27Oct 3, 2026: 28Oct 4, 2026: 28Oct 5, 2026: 26Oct 6, 2026: 27Oct 7, 2026: 28Oct 8, 2026: 28Oct 9, 2026: 29Oct 10, 2026: 29Oct 11, 2026: 29Oct 12, 2026: 28Oct 13, 2026: 27Oct 14, 2026: 26Oct 15, 2026: 27Oct 16, 2026: 26Oct 17, 2026: 26Oct 18, 2026: 27Oct 19, 2026: 28Oct 20, 2026: 29Oct 21, 2026: 29Oct 22, 2026: 29Oct 23, 2026: 27Oct 24, 2026: 27Oct 25, 2026: 28Oct 26, 2026: 28Oct 27, 2026: 29Oct 28, 2026: 29Oct 29, 2026: 30Oct 30, 2026: 29Oct 31, 2026: 28Nov 1, 2026: 30Nov 2, 2026: 27Nov 3, 2026: 28Nov 4, 2026: 30Nov 5, 2026: 27Nov 6, 2026: 27Nov 7, 2026: 28Nov 8, 2026: 28Nov 9, 2026: 29Nov 10, 2026: 29Nov 11, 2026: 29Nov 12, 2026: 25Nov 13, 2026: 27Nov 14, 2026: 27Nov 15, 2026: 27Nov 16, 2026: 27Nov 17, 2026: 27Nov 18, 2026: 27Nov 19, 2026: 27
Show the daily numbers
DateComposite
Nov 19, 202627
Nov 18, 202627
Nov 17, 202627
Nov 16, 202627
Nov 15, 202627
Nov 14, 202627
Nov 13, 202627
Nov 12, 202625
Nov 11, 202629
Nov 10, 202629
Nov 9, 202629
Nov 8, 202628
Nov 7, 202628
Nov 6, 202627
Nov 5, 202627
Nov 4, 202630
Nov 3, 202628
Nov 2, 202627
Nov 1, 202630
Oct 31, 202628
Oct 30, 202629
Oct 29, 202630
Oct 28, 202629
Oct 27, 202629
Oct 26, 202628
Oct 25, 202628
Oct 24, 202627
Oct 23, 202627
Oct 22, 202629
Oct 21, 202629
Oct 20, 202629
Oct 19, 202628
Oct 18, 202627
Oct 17, 202626
Oct 16, 202626
Oct 15, 202627
Oct 14, 202626
Oct 13, 202627
Oct 12, 202628
Oct 11, 202629
Oct 10, 202629
Oct 9, 202629
Oct 8, 202628
Oct 7, 202628
Oct 6, 202627
Oct 5, 202626
Oct 4, 202628
Oct 3, 202628
Oct 2, 202627
Oct 1, 202628
Sep 30, 202632
Sep 29, 202631
Sep 28, 202631
Sep 27, 202629
Sep 26, 202629
Sep 25, 202630
Sep 24, 202631
Sep 23, 202631
Sep 22, 202631
Sep 21, 202634
Sep 20, 202636
Sep 19, 202636
Sep 18, 202635
Sep 17, 202635
Sep 16, 202634
Sep 15, 202634
Sep 14, 202635
Sep 13, 202636
Sep 12, 202636
Sep 11, 202636
Sep 10, 202636
Sep 9, 202638
Sep 8, 202642
Sep 7, 202641
Sep 6, 202641
Sep 5, 202641
Sep 4, 202640
Sep 3, 202650
Sep 2, 202640
Sep 1, 202639
Aug 31, 202637
Aug 30, 202639
Aug 29, 202639
Aug 28, 202639
Aug 27, 202641
Aug 26, 202641
Aug 25, 202641
Aug 24, 202639
Aug 23, 202641
Aug 22, 202641

Key facts

Market cap
$1.1B
Sector
Healthcare
Industry
Biotechnology
Beta
1.42
Risk grade (1–10)
4
Next earnings
Nov 12, 2026

Questions

What is NKTR's stock rating today?

NKTR scores 27/100 (Bearish) as of Nov 19, 2026: technical 25, fundamental 28, and news sentiment 41, which is shown but not counted. Scores are recomputed every night.

What does Nektar Therapeutics do?

Nektar Therapeutics (NKTR) is a clinical-stage biotechnology company focused on treatments that work by modulating the immune system. Its lead product candidate is rezpegaldesleukin, often called rezpeg, a drug designed to stimulate regulatory T cells, which help calm overactive immune responses.

Is NKTR stock a buy?

The score is not a buy or sell recommendation. A 27 says the technical and fundamental signals we measure lean bearish today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the NKTR score calculated?

99 weighted scorers feed it today: 37 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.

Embed this score

A badge for a blog post, newsletter or README. It updates every night and links back here. More badges

NKTR stock score

HTML

<a href="https://stocksscores.com/stocks/nktr/"><img src="https://stocksscores.com/stocks/nktr/badge.svg" alt="NKTR stock score" height="20"></a>

Markdown

[![NKTR stock score](https://stocksscores.com/stocks/nktr/badge.svg)](https://stocksscores.com/stocks/nktr/)